Target Price | $166.90 |
Price | $107.80 |
Potential | 54.82% |
Number of Estimates | 30 |
30 Analysts have issued a price target Arm 2026 . The average Arm target price is $166.90. This is 54.82% higher than the current stock price. The highest price target is $225.00 108.72% , the lowest is $80.00 25.79% . | |
A rating was issued by 41 analysts: 23 Analysts recommend Arm to buy, 14 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Arm stock has an average upside potential 2026 of 54.82% . Most analysts recommend the Arm stock at Purchase. |
34 Analysts have issued a sales forecast Arm 2025 . The average Arm sales estimate is $4.0b . This is 8.34% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $4.1b 10.18% , the lowest is $4.0b 7.99% .
This results in the following potential growth metrics:
2024 | $3.2b | 20.68% |
---|---|---|
2025 | $4.0b | 23.79% |
2026 | $4.9b | 23.17% |
2027 | $6.0b | 22.12% |
2028 | $6.9b | 13.84% |
2029 | $8.1b | 18.28% |
16 Analysts have issued an Arm EBITDA forecast 2025. The average Arm EBITDA estimate is $2.0b . This is 227.83% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $2.1b 235.07% , the lowest is $1.8b 197.88% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $261m | 69.23% |
---|---|---|
2025 | $2.0b | 669.97% |
2026 | $2.6b | 28.35% |
2027 | $3.4b | 31.57% |
2028 | $4.2b | 22.56% |
2029 | $5.8b | 38.52% |
2024 | 8.07% | 74.50% |
---|---|---|
2025 | 50.21% | 521.95% |
2026 | 52.32% | 4.20% |
2027 | 56.37% | 7.74% |
2028 | 60.69% | 7.66% |
2029 | 71.07% | 17.10% |
20 Arm Analysts have issued a net profit forecast 2025. The average Arm net profit estimate is $941m . This is 17.46% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.0b 27.63% , the lowest is $822m 2.63% .
This results in the following potential growth metrics and future Net Margins:
2024 | $306m | 43.14% |
---|---|---|
2025 | $941m | 207.82% |
2026 | $1.4b | 46.09% |
2027 | $1.9b | 40.64% |
2028 | $2.6b | 32.76% |
2029 | $3.2b | 24.44% |
2024 | 9.45% | 52.88% |
---|---|---|
2025 | 23.51% | 148.67% |
2026 | 27.88% | 18.59% |
2027 | 32.11% | 15.17% |
2028 | 37.45% | 16.63% |
2029 | 39.40% | 5.21% |
20 Analysts have issued a Arm forecast for earnings per share. The average Arm EPS is $0.89 . This is 17.11% higher than earnings per share in the financial year 2024. The highest EPS forecast is $0.97 27.63% , the lowest is $0.78 2.63% .
This results in the following potential growth metrics and future valuations:
2024 | $0.29 | 43.14% |
---|---|---|
2025 | $0.89 | 206.90% |
2026 | $1.30 | 46.07% |
2027 | $1.83 | 40.77% |
2028 | $2.44 | 33.33% |
2029 | $3.03 | 24.18% |
Current | 142.24 | 91.71% |
---|---|---|
2025 | 120.76 | 15.10% |
2026 | 82.66 | 31.55% |
2027 | 58.78 | 28.89% |
2028 | 44.27 | 24.69% |
2029 | 35.58 | 19.63% |
Based on analysts' sales estimates for 2025, the Arm stock is valued at an EV/Sales of 27.79 and an P/S ratio of 28.39 .
This results in the following potential growth metrics and future valuations:
Current | 30.11 | 34.83% |
---|---|---|
2025 | 27.79 | 7.70% |
2026 | 22.56 | 18.81% |
2027 | 18.48 | 18.12% |
2028 | 16.23 | 12.16% |
2029 | 13.72 | 15.46% |
Current | 30.76 | 34.48% |
---|---|---|
2025 | 28.39 | 7.70% |
2026 | 23.05 | 18.81% |
2027 | 18.87 | 18.12% |
2028 | 16.58 | 12.16% |
2029 | 14.02 | 15.46% |
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Mar 28 2025 |
Loop Capital |
Buy
➜
Buy
|
Unchanged | Feb 10 2025 |
Benchmark |
Hold
➜
Hold
|
Unchanged | Feb 07 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Feb 06 2025 |
Benchmark |
Hold
➜
Hold
|
Unchanged | Feb 06 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Feb 06 2025 |
Jefferies |
Buy
➜
Buy
|
Unchanged | Feb 06 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Mar 28 2025 |
Unchanged
Loop Capital:
Buy
➜
Buy
|
Feb 10 2025 |
Unchanged
Benchmark:
Hold
➜
Hold
|
Feb 07 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Feb 06 2025 |
Unchanged
Benchmark:
Hold
➜
Hold
|
Feb 06 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Feb 06 2025 |
Unchanged
Jefferies:
Buy
➜
Buy
|
Feb 06 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.